Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 95.33% | -737.99% | 579.03% | 7.80% | 22.11% |
| Total Depreciation and Amortization | -50.00% | 0.00% | 100.00% | -50.00% | 100.00% |
| Total Amortization of Deferred Charges | 1.81% | -0.72% | 0.36% | 0.00% | -0.36% |
| Total Other Non-Cash Items | -98.88% | 557.80% | -113,620.00% | -97.42% | 846.15% |
| Change in Net Operating Assets | 102.67% | -196.40% | -120.63% | -1,150.00% | -98.91% |
| Cash from Operations | 45.70% | 2.26% | -92.94% | -38.17% | -11.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 0.00% | -- | -- |
| Cash from Investing | -- | -100.00% | 0.00% | -- | -- |
| Total Debt Issued | -- | 162.05% | -66.32% | 37.68% | 108.19% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -85.14% | 493.98% | 37.68% | 108.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.79% | -125.09% | -- | -100.00% | 100.50% |